Skip to main content
Screener/Healthcare/Biotechnology

SLS — SELLAS Life Sciences Group, Inc.

NASDAQ
$11.53-0.49 (-4.08%)
Mid CapUnder $20HealthcareHigh Beta
$1.39
$15.88
$11.49
$12.14
EPS (TTM)$-0.23
P/E Ratio-27.81
Dividend Yield—
Market Cap$2.14B
Volume1.73M
Prev Close$12.02
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$8.4M$-0.05——
Q4 '25$0-$7.7M$-0.05——
Q3 '25$0-$6.8M$-0.06——
Q2 '25$0-$6.6M$-0.07——
Q1 '25$0-$5.8M$-0.07——
Q4 '24$0-$6.7M$-0.09——
Q3 '24$0-$7.1M$-0.10——
Q2 '24$0-$7.5M$-0.13——
Get Your Daily Market Recap